ALDH1A1 and non-small cell lung carcinoma: Our findings of cisplatin-mediated induction of the CSC marker, ALDH1, in both parental and cisplatin resistant NSCLC cell lines, highlights the potential of cisplatin to select for, and expand, a CSC-like subpopulation of cells.